Systematic review / meta-analysis / 2018
E-cigarettes showed moderate efficacy for smoking reduction and cessation alongside frequently reported adverse events.
A systematic review and meta-analysis of 14 studies with 35,665 participants evaluated the efficacy and adverse events of electronic cigarettes. The pooled efficacy rate of e-cigarettes ranged from 48.3% to 58.7% for smoking reduction and from 13.2% to 22.9% for smoking cessation. Based on 11 studies with 16,406 participants, the pooled rate of adverse events ranged from 49.1% to 51.6%, with mouth or throat irritation, anxiety, depressed mood, nausea, and insomnia being most prevalent. Data from 5 studies showed no significant differences in overall CO exhalation (eCO) levels after e-cigarette use.
- Study type
- Systematic review and meta-analysis
- Who was studied
- 35,665 participants across 14 studies
- What was measured
- Smoking reduction, smoking cessation, adverse events, and CO exhalation (eCO) levels
THE PAPER
Efficiency and adverse events of electronic cigarettes: A systematic review and meta-analysis (PRISMA-compliant article).
Liu X, Lu W, Liao S, Deng Z, Zhang Z, Liu Y, Lu W. Medicine (Baltimore), 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.